Aktuelle Nachrichten bei Lam Pharma. (631629)!!! - 500 Beiträge pro Seite

[Ichtradegern]

Ich denke, die dürften heute anziehen...


Tuesday April 23, 7:10 am Eastern Time
Press Release
SOURCE: LAM Pharmaceutical Corp.
LAM IPM Wound Gel(TM) To Be Made Available Free of Charge To Healthcare Professionals For Compassionate Use Before Launch Date
LEWISTON, N.Y., April 23 /PRNewswire-FirstCall/ -- LAM Pharmaceutical, Corp. (Nasdaq: LAMP; FRANKFURT STOCK EXCHANGE: LAM; BERLIN: LAM), http://www.lampharm.com announced today that its approved device, (FDA Number K020325), LAM IPM Wound Gel(TM), will be made available to healthcare professionals for the most serious refractory (hard-to-heal) leg, foot and pressure ulcers (see accompanying product insert) at the earliest possible time.

LAM Pharmaceutical, Corp. has received numerous requests from healthcare professionals for LAM IPM Wound Gel(TM) to assist them in the management to their most difficult cases.

To receive free samples for compassionate treatment, healthcare professionals should e-mail us with their name, address and phone number as follows: [e-mail].

Consumers requiring information about programs, policies or procedures of the U.S. Food and Drug Administration Center for Devices and Radiological Health (DSMICA) should dial 301-827-3990 and press 5 during business hours, or e-mail [e-mail].


Approved Product Insert

"L.A.M. IPM WOUND GEL(TM)"

PRODUCT DESCRIPTION


L.A.M. IPM Wound Gel(TM) is a clear, viscous, odorless, aqueous gel composed principally of sodium hyaluronate, a derivative salt of Hyaluronic acid.

Hyaluronic acid is a naturally occurring molecule found in various parts of the body. Hyaluronic acid used in L.A.M. IPM Wound Gel(TM) is derived from avian sources. The gel has demonstrated to be of value in the management of certain skin ulcers and wounds where maintaining a moist environment is supportive of the healing process. In human skin hyaluronic acid is involved in such important biological functions as tissue hydration and proteoglycan organization (formation of proteins and sugars).

INDICATIONS

For over-the-counter use
L.A.M. IPM Wound Gel(TM) is suitable for:
* Minor abrasions
* Minor cuts

Under the supervision of a healthcare professional.
L.A.M. IPM Wound Gel(TM) is suitable for exuding wounds such as
* Leg ulcers
* Pressure ulcers
* Diabetic ulcers
* Management of mechanically or surgically debrided wounds.

CONTRAINDICATIONS


Do not administer to patients with known hyper-sensitivity to this product or to avian proteins.

WARNINGS

* The prolonged use of the product may give rise to sensitization
phenomena. Should this occur, discontinue use of the product
immediately and consult a healthcare professional.
* To prevent the possibility of cross infection, a tube of L.A.M.
IPM Wound Gel(TM) should be used on one patient only.
* Direct contact with the wound and the container should be avoided.
* Do not use in case of package damage.
* Do not use the product after the expiry date noted on package.
* Keep out of reach of children

PRECAUTIONS AND OBSERVATIONS

For over-the-counter use:
* If the wound appears to get larger after the first three or four
applications, discontinue use and consult a healthcare professional.
* Should you observe irritation, reddening, inflammation, maceration
(whitening of the skin), hyper granulation (excess tissue formation)
or sensitivity (allergic reaction), consult a healthcare professional
immediately.
* Consult a healthcare professional if:
1. Signs of infection occur, increased pain, bleeding, wound
drainage.
2. There is a change in wound color and/or odor.
3. The wound does not begin to show signs of healing in a few days.
4. Any other unexpected symptoms occur.
* When using L.A.M. IPM Wound Gel(TM) in combination with other wound
care products, always consult a healthcare professional.

Under the supervision of a healthcare professional:
* The treatment of any leg ulcers, pressure ulcers, diabetic ulcers and
surgically debrided wounds should be under the supervision of a
healthcare professional.
* Appropriate supportive measures should be taken where indicated
(e.g. use of graduated compression bandaging in the management of
venous leg ulcers or pressure relief measures in the management of
pressure ulcers).


NOTE: The control of blood glucose as well as appropriate pressure relief measures should be provided with diabetic foot ulcers.

* Colonization of chronic wounds is common and it is not a
contraindication to the use of L.A.M. IPM Wound Gel(TM). The dressing
may be used on infected wounds under medical supervision together with
appropriate therapy and frequent monitoring of the wound by the
healthcare professional.

HOW TO USE

1. First clean the ulcer or other wound with normal saline solution
(other cleansing agents are not recommended). Normal saline solution
can be obtained through your local pharmacy.


NOTE: Debridement (surgical cleansing) of the wound may be performed at the discretion of a healthcare professional.

2. Remove excess moisture with a dry gauze.
3. Apply L.A.M. IPM Wound Gel(TM) liberally into the cavity of the ulcer
or wound site and the surrounding area.
4. Apply a non-stick gauze dressing (Telfa(R) pad, Vaseline(R) Petroleum
Gauze or other suitable non-stick pad) over the wound site.


NOTE: Once L.A.M. IPM Wound Gel(TM) is applied the gel should not be touched.

5. Finally, wrap a self-adhesive bandage over the non-stick gauze
dressing.
6. Repeat the entire process of wound cleansing, applying L.A.M.
IPM Wound Gel(TM) and bandaging daily.
7. Visit a healthcare professional as recommended.

STORAGE


Store in a cool, dry place at room temperature. Temperature should not exceed 35 degrees C/95 degrees F. Protect from freezing.

FURTHER INFORMATION

If further information, contact:
L.A.M. Pharmaceutical, Corp.,
Professional Services Department
755 Center Street, Unit 5
Lewiston N.Y. 14092
1-877-526-7717 or [phone].
http://www.lampharm.com

In case of an emergency contact your healthcare professional.


Telfa® is a registered trademark of Tyco Health Care Group, L.P.

Vaseline® is a registered trademark of Cheseborough-Pond`s, Inc.

IPM and Ionic Polymer Matrix(TM) are trademarks of L.A.M. Pharmaceutical, Corp.

L.A.M. IPM Wound Gel(TM) is protected by one or more of the following patents: 5,897,880; 6,120,804; 6,007,843; 6,063,405.

About LAM Pharmaceutical, Corp.

LAM Pharmaceutical, Corp. is a biomedical company with laboratories in Lewiston, New York, and a business office in Toronto. LAM focuses on the development and commercialization of novel wound healing and transdermal drug delivery systems that offer patients, among other benefits, safer and more effective treatment for a variety of serious diseases. The technology is based on an original Ionic Polymer Matrix(TM) technology (IPM), a proprietary and patented combination (a total of ten U.S. issued and approved patents) of electrically charged and non-charged molecules with wound-healing properties. IPM technology is also appropriate for use with well-established drugs, allowing for the sustained delivery of greater amounts to the target areas than is otherwise possible by oral means, thus prolonging therapeutic activity.

The main ingredient of the Ionic Polymer Matrix(TM) technology is a derivative of hyaluronic acid, a molecule normally found in the skin, joints and bones. Hyaluronic acid is a non-immunogenic (the body does not react to it) and it is involved in such important biological functions as tissue hydration and proteoglycan organization (formation of proteins and sugars) to optimize tissue repair and prevent tissue aging. As well, hyaluronic acid is present in high concentrations in fetal skin where wound healing is rapid and leaves little scarring.

LAM IPM Wound Gel(TM) is a clear, viscous, aqueous, odorless gel composed principally of sodium hyaluronate, a derivative salt of Hyaluronic acid. LAM IPM Wound Gel(TM) has demonstrated in both human and animal trials to be of significant value in the management of certain skin ulcers and wounds where maintaining a moist environment is supportive of the healing process. In human skin, Hyaluronic acid is involved in such important biological functions as tissue hydration and proteoglycan organization (formation of proteins and sugars).
As of April 1, 2002, LAM had ten issued and allowed patents in the United States. LAM IPM Wound Gel(TM) is protected by one or more of the following patents: 5,887,880; 6,120,804; 6,007,843; 6,063,405. All referenced patents have been issued to LAM Pharmaceutical, Corp. by the United States Patent Office and have subsequently been filed on a global basis or are in the process of global filing.

The Company`s list of products under development include the following:

LAM IPM - Post Surgical Gel - An advanced IPM (ionic polymer matrix) designed for use on fresh surgical wounds (stapled or sutured) for the purpose of creating an environment conducive to improved healing.

LAM IPM - Extreme Dry Skin Formula - A gel formula designed to saturate the stratum corneum, to relieve the symptoms of eczema, dermatitis and extremely dry skin.

LAM IPM - Female Sexual Dysfunction Matrix - a product that provides enhanced lubrication while also allowing the external structures of the female genitalia to be flushed with greater blood supply.

LAM IPM - Motion Sickness Matrix - a product currently under development, which is a topically applied delivery system, using a patch, of a well-known motion sickness drug.

LAM IPM - Arthritic Pain Matrix - is a clear aqueous gel that contains a well proven off patent drug.

For more information please visit our website at http://www.lampharm.com or send us an e-mail at [e-mail] to receive the latest information and press releases.

Statements in this press release regarding our business which are not historical facts are ``forward-looking statements`` that involve risks and uncertainties which could cause the Company`s actual results and financial condition to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to uncertainties relating to the need for additional funds and corporate partners, product liability, dependence on third parties for manufacturing and marketing, the early stage of products being marketed or under development, patent risk and competition.

Company Contact: Anthony Vespa
Toll Free in N. America (877) LAM-7717
[phone]
Tel [phone]
Fax [phone]
Website: www.lampharm.com

Press Contact: Barry S. Kaplan
Barry Kaplan & Associates
Tel [phone]
Fax [phone]
[e-mail]

[Mordi]

@Ichtradegern:


Wenn Deine ID Deine Bestimmung ist, dann guckt Dir einmal Aspen Group (580803) an.

Der Hype bei LAMP ist (leider) genauso schnell verflogen, wie er gekommen ist !!!


Bei Aspen (Ex-Aussie Online) kann er täglich beginnen !!!

Ein idealer Wert (Australien) zum traden !!!

Schau Die einmal Hoch und Tief im April an 1!!!!

[SeriserAnleger]

@ Ichtradegern
Schau doch mal bitte in deine mailbox